Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
Authors
Keywords
-
Journal
ESMO Open
Volume 8, Issue 4, Pages 101587
Publisher
Elsevier BV
Online
2023-06-25
DOI
10.1016/j.esmoop.2023.101587
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- (2023) L.E. Hendriks et al. ANNALS OF ONCOLOGY
- Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
- (2023) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
- (2023) Toshiaki Takahashi et al. CANCER SCIENCE
- ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer
- (2022) A. Passaro et al. ANNALS OF ONCOLOGY
- Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
- (2022) Navneet Singh et al. JOURNAL OF CLINICAL ONCOLOGY
- Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
- (2022) Frédérique Penault-Llorca et al. VIRCHOWS ARCHIV
- MA12.05 Economic Impact of Delaying Care with Single-Gene Testing Versus Next-Generation Sequencing in Non-small Cell Lung Cancer
- (2022) B. Sheffield et al. Journal of Thoracic Oncology
- The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
- (2021) Keith M. Kerr et al. LUNG CANCER
- Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC).
- (2021) Debora S. Bruno et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathology molecular reflex testing improves turn-around-time and overall molecular testing rates in NSCLC.
- (2021) David R. Braxton et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarker tissue journey among patients (pts) with untreated metastatic non-small cell lung cancer (mNSCLC) in the U.S. Oncology Network community practices.
- (2021) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular testing in stage I–III non-small cell lung cancer: approaches and challenges
- (2021) Charu Aggarwal et al. LUNG CANCER
- P59.21 Impact of Reflex Testing on Pathology Based Molecular Testing in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- (2021) M. Marmarelis et al. Journal of Thoracic Oncology
- Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
- (2020) Nasser H. Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR mutation exists in squamous cell lung carcinoma
- (2020) Alvin Ho-Kwan Cheung et al. PATHOLOGY
- Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
- (2020) Kartik Anand et al. Clinical Lung Cancer
- Lung cancer biomarker testing: perspective from Europe
- (2020) Erik Thunnissen et al. Translational Lung Cancer Research
- Genomic testing and treatment landscape in patients with advanced non-small cell lung cancer (aNSCLC) using real-world data from community oncology practices.
- (2019) Hinco Jasper Gierman et al. JOURNAL OF CLINICAL ONCOLOGY
- The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
- (2019) Hsiang-Ling Ho et al. Diagnostic Pathology
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- (2018) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Impact of Reflex EGFR/ALK Testing on Time to Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2017) Parneet K. Cheema et al. Journal of Oncology Practice
- Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer†
- (2015) C. Lim et al. ANNALS OF ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations
- (2015) B. P. Levy et al. ONCOLOGIST
- Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification
- (2012) William D. Travis et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: Report on initial experience and clinical utility at a single center
- (2010) Sandra P. D’Angelo et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
- (2010) Peh Sun Loo et al. Journal of Thoracic Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now